BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28012245)

  • 1. Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.
    Tomizawa D; Endo A; Kajiwara M; Sakaguchi H; Matsumoto K; Kaneda M; Taga T
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28012245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.
    Murphy BR; Roth M; Kolb EA; Alonzo T; Gerbing R; Wells RJ
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27700. PubMed ID: 30908863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
    Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK
    Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
    Winick NJ; McKenna RW; Shuster JJ; Schneider NR; Borowitz MJ; Bowman WP; Jacaruso D; Kamen BA; Buchanan GR
    J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
    Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
    Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
    Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and survival of children with acute leukemia with Down syndrome or other birth defects in New York State.
    Qiao B; Austin AA; Schymura MJ; Browne ML
    Cancer Epidemiol; 2018 Dec; 57():68-73. PubMed ID: 30326394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma].
    Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W
    Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.
    Linabery AM; Blair CK; Gamis AS; Olshan AF; Heerema NA; Ross JA
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2572-7. PubMed ID: 18829445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
    Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
    Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
    O'Rafferty C; Kelly J; Storey L; Ryan C; O'Marcaigh A; Smith O
    Ir J Med Sci; 2015 Dec; 184(4):877-82. PubMed ID: 25344131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies.
    Hale GA; Heslop HE; Bowman LC; Rochester RA; Pui CH; Brenner MK; Krance RA
    Bone Marrow Transplant; 1999 Oct; 24(7):735-9. PubMed ID: 10516676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute leukemia in patients with Down syndrome].
    Fernández-Plaza S; Sevilla J; Contra T; Martín N; Madero L
    An Pediatr (Barc); 2004 Dec; 61(6):515-9. PubMed ID: 15574252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.
    Anderson CC; Goldstone AH; Linch DC; Jones HM; Franklin IM; Boughton BJ; Cawley JC; Richards JD
    Bone Marrow Transplant; 1987 Feb; 1(3):271-9. PubMed ID: 3332138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations.
    Litz CE; Davies S; Brunning RD; Kueck B; Parkin JL; Gajl Peczalska K; Arthur DC
    Leukemia; 1995 Sep; 9(9):1432-9. PubMed ID: 7658708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.